Clinical correlates and mortality impact of left ventricular hypertrophy among new ESRD patients in the United States

American Journal of Kidney Diseases

Volumn 40, Issue 6, 2002, Pages 1202-1210

  Stack, Austin G ^a,b,c,d   Saran, Rajiv ^a,b,c  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF TEXAS   (United States)

Author keywords

End stage renal disease (ESRD); Left ventricular hypertrophy (LVH); Outcomes research; Prevalence

Indexed keywords

CALCIUM; PARATHYROID HORMONE; SERUM ALBUMIN;

ADULT; AGE; AGED; ARTICLE; CALCIUM BLOOD LEVEL; CORONARY RISK; CORRELATION ANALYSIS; DIABETES MELLITUS; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOMES RESEARCH; PARATHYROID HORMONE BLOOD LEVEL; PERICARDITIS; PREVALENCE; RISK ASSESSMENT; SMOKING; SURVIVAL RATE; UNITED STATES; UREMIA;

EID: 0036897093     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2002.36881     Document Type: Article

References (23)

1. Foley RN, Parfrey PS, Harnett JD, et al: Clinical and echocardiographic disease in patients starting end stage renal disease therapy. Kidney Int 47:186-192, 1995
2. Levin A, Thompson C, Ethier J, et al: Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobin. Am J Kidney Dis 34:125-134, 1999
3. McKee PA, Castelli WP, McNamara PM, Kannel WB: The natural history of congestive heart failure: The Framingham study. N Engl J Med 285:1441-1446, 1971
4. Foley RN, Parfrey PS, Harnett JD, et al: The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol 5:2024-2031, 1995
5. US Renal Data System: Comorbid conditions and correlations with mortality risk among 3,399 incident hemodialysis patients. Am J Kidney Dis 20:32-38, 1992
6. Levy D, Garrison RH, Savage D, et al: Prognostic implication of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322:1561-1566, 1990
7. Schrimer H, Lunde P, Rasmussen K: Prevalence of left ventricular hypertrophy in a general population. The Tromso Study. Eur Heart J 20:429-438, 1999
8. Harnett JD, Kent GM, Barre PE, Taylor R, Parfrey PS: Risk factors for the development of left ventricular hypertrophy in a prospectively followed cohort of dialysis patients. J Am Soc Nephrol 4:1486-1490, 1994
9. Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray DC, Barre PE: Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transplant 11: 1277-1285, 1996
10. US Renal Data System: USRDS 1997 Annual Data Report. The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 1997, chapt IV
11. Levey AS, Bosch JP, Breyer Lewis J, Greene T, Rogers N, Roth D: MDRD Study Group: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med 130:461-470, 1999
12. Schmieder, RE, Martus P, Klingbeil A: Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies. JAMA 275:1507-1513, 1996
13. Devereux RB: Therapeutic options in minimizing left ventricular hypertrophy. Am Heart J 139:9-14, 2000
14. Longenecker JC, Coresh J, Powe NR: Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: The CHOICE Study. J Am Soc Nephrol 13:1918-1927, 2002
15. Savage T, Giles M, Tomson CV, Raine AEG: Gender differences in mediators of left ventricular hypertrophy in dialysis patients. Clin Nephrol 2:107-112, 1998
16. Weidman P, Maxwell MN, Lupu AN, et al: Plasma rennin activity and blood pressure in terminal renal failure. N Engl J Med 285:757-762, 1971
17. Raczynski JM, Taylor H, Cutter G, Hardin M, Rappaport N, Oberman A: Rose Questionnaire responses among black and white inpatients admitted for coronary heart disease: Findings from the Birmingham-BHS Project. Ethn Dis 3:290-302, 1993
18. Peterson ED, Wright SM, Daly J, Thibault GE: Racial variation in cardiac procedure use and survival following acute myocardial infarction in the Department of Veteran Affairs. JAMA 271:1175-1180, 1994
19. London GM, DeVenejoul MC, Fabiani F, et al: Secondary hyperparathyroidism and cardiac hypertrophy in hemodialysis patients. Kidney Int 32:900-907, 1987
20. Rostand SG, Drueke TB: Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure. Kidney Int 56:383-392, 1999
21. Amann K, Tornig J, Flechtenmacher C, Nabokov A, Mall G, Ritz E: Blood-pressure-independent wall thickening of intramyocardial arterioles in experimental uraemia: Evidence for a permissive action of PTH. Nephrol Dial Transplant 10:2043-2048, 1995
22. Amann K, Ritz E: Cardiac disease in chronic uremia: Pathophysiology. Adv Ren Replace Ther 4:212-224, 1997
23. London GM, Pannier B, Guerin A, et al: Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: Follow-up of an interventional study. J Am Soc Nephrol 12:2759-2767, 2001